Juvenile idiopathic arthritis in relation to maternal prenatal smoking

Susan Shenoi1, Samantha Bell, Carol A Wallace

  • 1University of Washington School of Medicine and Seattle Children's Hospital, Seattle.

Arthritis Care & Research
|September 10, 2014
PubMed

Insights

Maternal prenatal smoking was not associated with an increased risk of juvenile idiopathic arthritis (JIA). This study found no evidence linking prenatal smoking exposure to JIA development in children.

Area of Science:

  • Pediatric Rheumatology
  • Environmental Epidemiology
  • Childhood Arthritis

Background:

  • Cigarette smoking is a known risk factor for adult rheumatoid arthritis.
  • The association between prenatal smoking and juvenile idiopathic arthritis (JIA) remains unestablished.
  • JIA is a complex condition encompassing seven distinct categories of chronic childhood inflammatory arthritis.

Purpose of the Study:

  • To investigate the relationship between maternal prenatal smoking and the incidence of JIA.
  • To examine the association between prenatal smoking and specific JIA categories.

Main Methods:

  • A case-control study involving 1,196 JIA cases and 5,618 controls identified through hospital records and birth certificates.
  • Prenatal smoking exposure was determined from birth certificates.
  • JIA was categorized using the International League of Associations for Rheumatology criteria, with adjusted odds ratios calculated via logistic regression.

Main Results:

  • No increased risk of JIA was observed in relation to maternal prenatal smoking.
  • Mothers of JIA cases reported less prenatal smoking (11%) compared to control mothers (17%).
  • A potential inverse association was noted, particularly for oligoarticular/extended oligoarticular JIA, though residual confounding by socioeconomic status cannot be excluded.

Conclusions:

  • Maternal prenatal smoking is not linked to an increased risk of developing JIA.
  • The study did not find an association between prenatal smoking and individual JIA categories.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
35